波多野结衣办公室双飞_制服 丝袜 综合 日韩 欧美_网站永久看片免费_欧美一级片在线免费观看_免费视频91蜜桃_精产国品一区二区三区_97超碰免费在线观看_欧美做受喷浆在线观看_国产熟妇搡bbbb搡bbbb_麻豆精品国产传媒

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Americas

Conquering malaria remains a daunting dilemma

By CHRIS DAVIS | chinadaily.com.cn | Updated: 2017-04-26 10:41
Share
Share - WeChat

The war against malaria has made progress over the past decade, but there is still a long way to go, and Chinese researchers are leading the way on more than one front.

Roughly half of the world's population — 3 billion people — still remain at risk.

In 2006, there were 266 million cases a year leading to 750,000 deaths, according to the World Health Organization.

By 2015, the numbers had diminished, but remained huge — 212 million cases, 429,000 deaths.

And a staggering 90 percent of all cases are in Africa.

Dr Deng Changsheng, manager of the department of science and technology at Guangzhou University of Chinese Medicine, told a group of 27 journalists visiting from Africa recently, that strategy used to cause a major decline in malarial regions of China is showing promise in Africa.

The approach is called fast elimination of malaria by source eradication (FEMSE). It involves mass drug administration (MDA) of Artemisinin-based combination therapies (ACT) —in other words, clearing an affected population of the malarial parasites by mass drug administration.

Artemisinin, by the way, is the drug that won 85-year-old Chinese pharmacologist Tu Youyou the 2015 Nobel Prize for Medicine. She had mined the recipe,derived from the sweet wormwood plant, from the annals of ancient Chinese medicine. Today it saves 100,000s of lives a year in Africa alone.

The drug has not been cheap, but Deng said the cost could be brought to as low as $15 per person over the next decade. Today it's about $40, according to Deng.

Thanks to a worldwide push, ACT treatments rose from 187 million in 2010 to 311 million in 2015.

The big fear facing the effort right now is that the parasites are showing signs of developing a resistance to artemisinin, the same way some strains of tuberculosis are shunning off some of modern medicine's most potent antibiotics.

"The spread of artemisinin resistance in Africa would be a major setback in the fight against malaria, as ACT is the only affective and widely used anti-malarial treatment at the moment," writes Professor Arnab Pain of King Abdullah University of Science and Technology in the current issue of the New England Journal of Medicine.

"Therefore it is very important to regularly monitor artemisinin resistance on a worldwide scale," he added.

The study, led by Jun Cao of the Institute for Parasitic Diseases in China, found drug-resistant malarial parasites in a Chinese patient who had been in Equatorial Guinea and returned to China. The ACT therapy, which usually takes three days to rid the patient of the disease, took five days in this case.

This "partial resistance", they said, has been noted in other parts of Southeast Asia, and the great fear is that "partial" morphs into "complete."

"This is one of the great challenges facing us in the fight against malaria," the World Health Organization says on its website.

The Holy Grail of that fight, of course, remains a vaccine, and the Associated Press reports that three African nations have just been chosen to test the world's first malaria vaccine.

WHO announced Monday that Ghana, Kenya and Malawi will begin piloting an injectable vaccine next year with hundreds of thousands of young children, who have been at highest risk of death.

The vaccine, which has partial effectiveness, has the potential to save tens of thousands of lives if used with existing measures, WHO's regional director for Africa, Dr Matshidiso Moeti, said in a statement. The challenge is whether impoverished countries can deliver the required four doses of the vaccine for each child.

The vaccine will be tested on children five to 17 months old to see whether its protective effects shown so far in clinical trials can hold up under real-life conditions. At least 120,000 children in each of the three countries will receive the vaccine, which has taken decades of work and hundreds of millions of dollars to develop.

Kenya, Ghana and Malawi were chosen for the vaccine pilot because all have strong prevention and vaccination programs but continue to have high numbers of malaria cases, WHO said. The countries will deliver the vaccine through their existing vaccination programs.

WHO is hoping to wipe out malaria by 2040, despite the increasing resistance problems to both drugs and insecticides used to kill mosquitoes.

The vaccine was developed by GlaxoSmithKline, and the $49 million for the first phase of the pilot is being funded by the global vaccine alliance GAVI, UNITAID and Global Fund to Fight AIDS, Tuberculosis and Malaria.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
波多野结衣办公室双飞_制服 丝袜 综合 日韩 欧美_网站永久看片免费_欧美一级片在线免费观看_免费视频91蜜桃_精产国品一区二区三区_97超碰免费在线观看_欧美做受喷浆在线观看_国产熟妇搡bbbb搡bbbb_麻豆精品国产传媒
欧美人妻一区二区三区| 久久综合五月天婷婷伊人| 亚洲欧洲成人自拍| 国产 欧美在线| 肉色超薄丝袜脚交69xx图片| 久久―日本道色综合久久| 精品在线视频一区| 欧美做受xxxxxⅹ性视频| 精品国产免费一区二区三区四区| 日本aⅴ亚洲精品中文乱码| 丰满大乳奶做爰ⅹxx视频 | 久久美女艺术照精彩视频福利播放 | 日韩久久一区二区| 波多野结衣视频一区| 成人羞羞国产免费图片| 国产传媒日韩欧美成人| 日本成人午夜影院| 2023国产精华国产精品| 国产一区二区在线视频| 免费黄色国产视频| 国产精品伦理在线| 99国产精品视频免费观看| 欧美综合天天夜夜久久| 亚洲成av人综合在线观看| 日韩精品视频一区二区| 欧美成人精精品一区二区频| 久久av资源网| 任我爽在线视频| 亚洲女性喷水在线观看一区| 国产伦精品一区二区三区妓女下载 | 精品精品欲导航| 久久爱www久久做| 日韩av网站在线播放| 亚洲欧洲精品一区二区三区不卡| 免费看的av网站| 日韩一区二区免费在线电影| 免费高清不卡av| 任你操精品视频| 亚洲男人的天堂一区二区| 蜜臀av粉嫩av懂色av| 精品99久久久久久| 暴力调教一区二区三区| 欧美日韩久久久| 开心九九激情九九欧美日韩精美视频电影| 成人做爰69片免网站| 亚洲日本护士毛茸茸| 欧美夫妇交换xxx| 久久久久久久国产精品影院| heyzo一本久久综合| 欧美精品18+| 国产精品一区二区久激情瑜伽| 日本电影亚洲天堂一区| 日韩国产在线观看一区| 国内毛片毛片毛片毛片毛片| 一区二区不卡在线视频 午夜欧美不卡在| 成人免费无码大片a毛片| 日本一区二区三区在线不卡| 熟女人妻一区二区三区免费看| 26uuu亚洲综合色欧美 | 99re在线精品| 日韩精品一区二区三区四区| 成人少妇影院yyyy| 日韩一区二区在线观看| 成人性生交大片免费看中文 | 国产精品国产成人国产三级| av无码一区二区三区| 国产精品视频免费看| 亚洲一区二区在线免费| 国产精品麻豆久久久| 国产熟女高潮一区二区三区| 亚洲欧洲另类国产综合| 国产 欧美 在线| 亚洲一级电影视频| 免费精品在线视频| 日本视频一区二区| 在线亚洲+欧美+日本专区| 国产综合色在线视频区| 欧美精品一二三区| 成人免费视频网站在线观看| 精品国免费一区二区三区| 岛国大片在线免费观看| 中文字幕av不卡| 偷拍夫妻性生活| 亚洲成年人影院| 色婷婷亚洲婷婷| 国产麻豆欧美日韩一区| 日韩欧美国产高清| 国产伦精品一区二区三区妓女下载| 国产日韩精品一区二区三区| 日本黄色网址大全| 亚洲国产精品一区二区久久| 一道本成人在线| 国产精品一级在线| 337p日本欧洲亚洲大胆色噜噜| 精品一区二区视频在线观看| 一区二区三区在线观看网站| 中文字幕电影av| 国产麻豆视频一区二区| 精品久久五月天| 在线免费观看污视频| 亚洲国产中文字幕在线视频综合 | 日本中文在线视频| 久久不见久久见免费视频7| 欧美一级片免费看| 超碰caoprom| 亚洲综合一二区| 91福利精品视频| 不卡欧美aaaaa| 国产精品久久免费看| 国产又黄又粗又猛又爽的| 精品综合久久久久久8888| 日韩精品一区在线观看| 欧洲一级黄色片| 视频一区二区三区入口| 欧美高清性hdvideosex| 苍井空张开腿实干12次| 一区二区三区在线视频免费 | 色国产综合视频| 成人精品国产一区二区4080| 国产精品―色哟哟| 天海翼在线视频| 成人免费三级在线| 国产精品国产自产拍高清av| 国产三级国产精品国产国在线观看| 国产精品一区二区久久精品爱涩| 国产欧美视频在线观看| 亚洲女人毛茸茸高潮| 国产高清在线观看免费不卡| 国产欧美久久久精品影院 | 精品亚洲成av人在线观看| 欧美精品一区二区三区在线播放| 三级网站在线免费观看| 捆绑调教一区二区三区| 久久网站热最新地址| 亚洲激情图片网| 成人国产精品免费观看视频| 亚洲欧美日韩人成在线播放| 欧洲精品视频在线观看| 农村末发育av片一区二区| 婷婷综合五月天| 精品国免费一区二区三区| 亚洲一级理论片| 成人ar影院免费观看视频| 亚洲精品伦理在线| 欧美放荡的少妇| 人妻体内射精一区二区| 国产一二精品视频| 中文字幕综合网| 欧美日韩精品一区二区| 亚洲色图14p| 国产做a爰片久久毛片| 中文字幕在线观看一区| 在线国产亚洲欧美| 性久久久久久久久久久| 国产在线一区观看| 国产精品福利一区二区| 欧美日韩一区国产| 亚洲成人网在线播放| 国产成人综合在线| 一区二区日韩电影| 欧美成人在线直播| 国产老头老太做爰视频| 性xxxxxxxxx| 久久精品国产成人一区二区三区 | 欧美日本一区二区| 亚洲人成人无码网www国产| 国产91精品在线观看| 亚洲制服丝袜一区| 亚洲精品在线观| 色噜噜狠狠色综合欧洲selulu | 亚洲男人的天堂av| 欧美成人国产一区二区| 亚洲成人生活片| 国产xxxxxxxxx| 国产福利一区二区三区视频在线| 亚洲精品日产精品乱码不卡| 日韩精品一区二区三区四区 | 日本韩国精品一区二区在线观看| 久久久午夜精品福利内容| 国产精品一级片| 亚洲成人777| 国产欧美综合在线| 欧美挠脚心视频网站| 青青青视频在线免费观看| av地址在线观看| 黄一区二区三区| 亚洲综合999| 国产亚洲视频系列| 欧美日本乱大交xxxxx| 天天色影综合网| 国产三级国产精品| 床上的激情91.| 日av在线不卡| 亚洲精品乱码久久久久久黑人 | 亚洲第一福利一区| 国产精品丝袜一区| 日韩欧美你懂的| 欧美色男人天堂| 午夜精品一区二区三级视频| 久久精品一区二区免费播放|